Nestle Shares Upbeat As Earnings Beat Estimates, Announces JV With Dr. Reddy's
Take Stock Of The Week Ahead

Get all the latest Share Market trends and news to set you up for the week ahead.

Congratulations!
You have successfully subscribed.

Nestle’s share price was upbeat after the company posted its results for the quarter ended March.

What Happened: The FMCG giant on Thursday reported a 27% jump in its net profit at ₹934.17 crore for the March quarter, compared to the ₹736.6 crore posted in the same quarter last year. The company’s revenue for the quarter came in at ₹5,267.5 crore, up around 9% from the year-ago period. Both the bottom and topline were above street estimates.

Total sales and Domestic sales for the quarter increased by 9.3% and 8.9%, respectively. Export sales for the quarter increased by 19.0%. EBITDA for the quarter stood at ₹1,337.7 crore, up 21.8% from the year-ago period. EBITDA margin was at 25.4%. The company also announced a dividend of ₹8.5/share.

See also: Tata Group Stock Falling After Q4, But Brokerages Raise Target Price

The company also shared its outlook on commodity prices going forward. Coffee and Cocoa are at all-time high prices and the rally is still ongoing. “Cereals and grains are going through a structural cost increase backed by MSP. Milk prices expected to rise on account of expected harsh summer,” the company said in a statement.

The FMCG major also announced a joint venture with pharma giant Dr. Reddy’s Laboratories for investing in Dr. Reddy’s Nutraceuticals Ltd. The Joint Venture will see Nestle India hold a 49% stake.

Price Action: Nestle’s share price was up 0.55% to trade at ₹2,513.80 in the mid-market hours of trading on Thursday.

Read next: Railway Stock Extends Gains To 4th Day After Bagging ₹239 Cr Order

Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

Comments
Loading...
EarningsEquitiesNewsMarketsMoversTrading IdeasNestle